Cameron Bruggeman
Overview
Explore the profile of Cameron Bruggeman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
6669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rizvi N, Hellmann M, Snyder A, Kvistborg P, Makarov V, Havel J, et al.
Science
. 2015 Mar;
348(6230):124-8.
PMID: 25765070
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome...
2.
Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky J, Desrichard A, et al.
N Engl J Med
. 2014 Nov;
371(23):2189-2199.
PMID: 25409260
Background: Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs...